Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured f...

FDA Recall #D-0470-2023 — Class II — March 10, 2023

Recall #D-0470-2023 Date: March 10, 2023 Classification: Class II Status: Ongoing

Product Description

Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.

Reason for Recall

Defective Delivery System: Out of specification for shear.

Recalling Firm

Noven Pharmaceuticals Inc — Miami, FL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

N/A

Distribution

US Nationwide

Code Information

Lot#: 91955, Exp. 7/2023; 93039, Exp. 10/2023

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls